The project logo was created by artist and SON member, Emily Kewageshig.

The Saugeen Ojibway Nation (SON) and Bruce Power are excited to introduce a new project name and logo for their medical isotope partnership. The project name, “Gamzook’aamin aakoziwin” translates to “We are teaming up on the sickness.” The Anishinaabemowin (Ojibwe or Anishinaabe language) name was developed through consultation with SON Knowledge Holder Polly Keeshig-Tobias and her collaboration with other SON knowledge holders and elders, said a joint media release October 21.

The project logo was created by artist and SON member, Emily Kewageshig, and represents a diversity of people working together towards healing, and is surrounded by a globe to capture the role that medical isotopes play in the global fight against cancer.

Mike Rencheck, Bruce Power's President and CEO said the project name and logo embody the spirit of the partnership, and the opportunity to have a positive impact of those impacted by cancer. "Together, we are teaming up to fight the sickness," he said.

“Working together with Bruce Power, SON is playing a leadership role in the fight against cancer while at the same time building economic opportunities for our territory, for our people and our communities," said Chief Greg Nadjiwon, Chippewas of Nawash Unceded First Nation.

“The Gamzook’aamin aakoziwin project will deliver benefits well outside the borders of our local community,” said Chief Lester Anoquot, Chippewas of Saugeen First Nation. “The advancement of this critical project sends a strong message across Canada and the world that we are committed to doing our part in the fight against cancer.”

SON and Bruce Power entered into a collaboration agreement in 2019 to explore ways of jointly marketing new isotopes in support of the global fight against cancer, while also working together to create new economic opportunities within the SON territory. The partnership will use the made-in-Ontario Isotope Production System installed into Bruce Power’s nuclear reactors to produce Lutetium-177 and other isotopes used in the diagnosis and treatment of cancers in hospitals around the world.